Stockholm - Free Realtime Quote SEK
Elicera Therapeutics AB (publ) (ELIC.ST)
4.6900
-0.3100
(-6.20%)
As of 3:23:30 PM GMT+2. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-23,463.1650
-23,463.1650
-14,922.5120
-8,570.8200
-14,293.1020
Investing Cash Flow
0
0
483.1700
0
-1
Financing Cash Flow
20,479.3060
20,479.3060
0
0
55,122.4530
End Cash Position
26,399.1080
26,399.1080
29,382.9670
43,822.3090
52,393.1290
Capital Expenditure
--
--
-1
--
--
Issuance of Capital Stock
20,479.3060
20,479.3060
0
0
55,122.4530
Free Cash Flow
-23,463.1650
-23,463.1650
-14,923.5120
-8,570.8200
-14,293.1020
12/31/2021 - 6/11/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
XSPRAY.ST Xspray Pharma AB (publ)
33.40
+2.45%
EGTX.ST Egetis Therapeutics AB (publ)
3.5300
-3.29%
ONCO.ST Oncopeptides AB (publ)
2.0250
+3.32%
ATORX.ST Alligator Bioscience AB (publ)
3.8590
-0.90%
1GDA.BE Zevra Therapeutics Inc
7.45
+8.76%
P0F.F Egetis Therapeutics AB (publ)
0.3065
-8.10%
ACE.ST Ascelia Pharma AB (publ)
3.8450
-1.03%
MVIR.ST Medivir AB (publ)
1.8000
-0.55%
SYNACT.ST SynAct Pharma AB
18.80
+2.96%
XINT.ST Xintela AB (publ)
0.4160
-7.56%